Capvaxive (Pneumococcal 21-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe
- RxCUI
- 2686978
- RxNorm name
- Capvaxive (Pneumococcal 21-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe
- Display name
- Capvaxive (Pneumococcal 21-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe
- Full name
- Capvaxive (Pneumococcal 21-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125814 | CAPVAXIVE | Pneumococcal 21-valent Conjugate Vaccine | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a264c2f-d2f8-4ab5-bc5e-fbed0001ede6 | CAPVAXIVE vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus p [SBD] · Capvaxive (Pneumococcal 21-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe [SY] | 3 | 4 | These highlights do not include all the information needed to use CAPVAXIVE safely and effectively. See full prescribing information for CAPVAXIVE. CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) injection, for intramuscular use Initial U.S. Approval: 2024 | 20250731 |